Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

10:00am, Monday, 04'th Nov 2024

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Aamir Malik, Chief U.S. Commercial Officer, Executive V

Is Pfizer Stock a Bargain for Long-Term Investors?

07:15am, Monday, 04'th Nov 2024

Wall Street's bearish take on this proven innovator may not be warranted.

2 Sensational Growth Stocks to Buy at a Discount

11:30am, Sunday, 03'rd Nov 2024

These growth stocks are looking especially attractive right now.

This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?

09:53am, Sunday, 03'rd Nov 2024

Slowly but surely, the company's prospects are looking more attractive.

3 Potential Catalysts That Could Lift Pfizer Stock Before 2025

08:33am, Sunday, 03'rd Nov 2024

The pipeline could yield a winner, but so could a few organizational changes.

Pfizer Is A Good Stock To Buy After The Earnings

12:06am, Sunday, 03'rd Nov 2024

PFE has beaten analyst estimate both top- and bottom line. The firm has also raised its full-year guidance. Investors have not taken the earnings news too positively, however, because significant port

Baby Boomers: 2 Super-High-Yield Stocks to Watch in November

09:50am, Friday, 01'st Nov 2024

Baby Boomer investors who aren't happy with the falling rates on their savings and CDs may be enticed by the dividend stocks right about now.

Pfizer: Overstated Pessimism Makes Little Sense

11:31am, Thursday, 31'st Oct 2024

Pfizer scored a double beat on revenue and adjusted EPS, bolstered by the surprising performance of its COVID franchise. Despite that, the lukewarm post-earnings response suggests Pfizer needs to flex

Pfizer CEO on Q3 earnings, exceptional with phenomenal growth

11:07am, Thursday, 31'st Oct 2024

After Pfizer (PFE) posted a third quarter earnings beat and raised its full-year guidance, CEO Albert Bourla joins Market Domination to discuss the "exceptional quarter." Bourla notes that Pfizer in a

3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might Think

05:41am, Thursday, 31'st Oct 2024

Pfizer's dividends should keep flowing and growing.

Pfizer Covid sales boost prompts durability concerns - Bank of America

03:15pm, Wednesday, 30'th Oct 2024

Pfizer Inc (NYSE:PFE, ETR:PFE)'s reliance on a rebound in demand for Covid-19 products in expectation-beating third-quarter results likely hit sentiment, according to Bank of America analysts. Though

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by